Fundraising FoxNew Frontier Bio
Beverly, US · Founded 2020 · Delaware corporation · 1 known investors
Find your way into New Frontier Bio
Sign up to see every warm intro you have to New Frontier Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the New Frontier Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
New Frontier Bio is a biotechnology company with a cross-functional management team experienced in start-ups, science, strategy, and M&A across healthcare, biotechnology, and cosmetics.
Founders & leadership
New Frontier Bio was founded in 2020 by Brad Pentelute.
BP
Brad PenteluteCo-Founder
JP
James P. LintonNamed on SEC filing
KK
Kevin KongCOO & President
VM
Vincent MaiNamed on SEC filing
KW
Kaiyuan WangNamed on SEC filing
SS
Serge SchoenNamed on SEC filing
SK
Stephen Kennedy SmithNamed on SEC filing
Board
SK
Steven Kennedy SmithChairman
Investors · 1
Reported raises · per SEC filings
Form D private placements$9.2M disclosed across 2 rounds · 2022–2024
▶$308.7KraisedJun 2024 · 6 investors · OtherRule 506(b)
▶$308.7KraisedJun 2024 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Kevin KongExecutive Officer
- Serge SchoenDirector
- Vincent MaiDirector
- Kaiyuan WangDirector
- Stephen SmithExecutive Officer, Director, Promoter
- James LintonDirector
- Offering amount
- $2M
- Amount sold
- $308.7K
- Minimum investment
- $6.8K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$8.9MraisedSep 2022 · 11 investors · OtherRule 506(b)
▶$8.9MraisedSep 2022 · 11 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- James P. LintonDirector, Promoter
- Kevin KongExecutive Officer
- Vincent MaiDirector
- Kaiyuan WangDirector
- Serge SchoenDirector
- Stephen Kennedy SmithExecutive Officer, Director, Promoter
- Offering amount
- $12M
- Amount sold
- $8.9M
- Minimum investment
- $40K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Frontier BioFrontier Bio develops tissue engineering and bioprinting technology, including fabrication of tissue-engineered blood vessels for clinical and in vitro applications. The company works at the intersection of biology and engineering in the biotech and medical device space.
Frontier MedicinesFrontier is a drug discovery company developing small-molecule covalent drugs aimed at previously undruggable protein targets across the proteome. It uses a platform that maps druggable sites to generate a pipeline of novel therapeutic leads.
bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Companies working in the same space as New Frontier Bio.
Frequently asked questions
- What does New Frontier Bio do?
- New Frontier Bio is a biotechnology company with a cross-functional management team experienced in start-ups, science, strategy, and M&A across healthcare, biotechnology, and cosmetics.
- Who founded New Frontier Bio?
- New Frontier Bio was founded by Brad Pentelute in 2020.
- Who are New Frontier Bio's investors?
- New Frontier Bio's investors include Taihill Venture.
- How much funding has New Frontier Bio raised?
- New Frontier Bio has disclosed $9.2M raised across 2 rounds.
- Where is New Frontier Bio headquartered?
- New Frontier Bio is headquartered in Beverly, US.